Paediatric poisoning

Published on 27/02/2015 by admin

Filed under Anesthesiology

Last modified 27/02/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1305 times

Chapter 105 Paediatric poisoning

EPIDEMIOLOGY

The peak incidence of poisoning in childhood is among 1–4 year olds. It usually occurs in the home when the child ingests a single prescribed or over-the-counter medication or a household product. Approximately 3500 young children are admitted to hospital each year in Australia.1 This mode of poisoning is called ‘accidental’ – erroneously because it is usually the result of inadequate supervision or improper storage of poisons. The mortality is very low and if hospitalisation is required, it is usually brief (1–3 days). In this circumstance, care must be taken to ensure that whatever treatment is applied, it does not impose additional risk.

Occasionally, poisoning in childhood is either truly accidental as in ingestion of a decanted chemical, or is part of a syndrome of child abuse (Munchausen syndrome by proxy), or is iatrogenic as when a parent mistakes medications at home or when medical or nursing staff make errors in drug administration in hospital. Medication errors occur in approximately 5% of paediatric inpatient medication.2 Self-poisoning in older children is usually with the intention to manipulate their psychosocial environment or to commit suicide, or is the result of substance abuse. All circumstances of poisoning require remedial action.

PRINCIPLES OF MANAGEMENT

The four basic principles in management of poisoning are:

Table 105.1 Antidotes to some serious poisons

Poison Antidotes Comments
Amfetamines Esmolol i.v. 500 μg/kg over 1 min, then 25–200 μg/kg per min Treatment for tachyarrhythmia
  Labetalol i.v. 0.15–0.3 mg/kg or phentolamine i.v. 0.05–0.1 mg/kg every 10 minutes Treatment for hypertension
Benzodiazepines Flumazenil i.v. 3–10 μg/kg, repeat 1 minute, then 3–10 μ/kg per hour Specific receptor antagonist. Beware convulsions
β-Blockers Glucagon i.v. 7 μg/kg, then 2–7 μg/kg per min Stimulates non-catecholamine cAMP (preferred antidote)
Isoprenaline i.v. 0.05–3 μg/kg per min Beware β2 hypotension
Noradrenaline i.v. 0.05–1 μg/kg per min Antagonises at receptors
Calcium channel blocker Calcium chloride i.v. 10%, 0.2 ml/kg Antagonises at receptors
Carbon monoxide Oxygen 100% Decreases carboxyhaemoglobin. May need hyperbaric oxygen
Cyanide Dicobalt edetate i.v. 4–7.5 mg/kg Give 50 ml 50% glucose after dose
Hydroxocobalamin (vitamin B12) i.v. 70 mg/kg Beware anaphylaxis, hypertension
Amyl nitrite 0.2 ml perles by inhalation until sodium nitrite 3% i.v. 0.13–0.33 ml/kg over 4 min, then sodium thiosulphate 25% i.v. 1.65 ml/kg (max 50 ml) at 3–5 minutes Beware hypotension. Nitrites form methaemoglobin–cyanide complex. Beware excess methaemoglobin >20%. Thiosulphate forms non-toxic thiocyanate from methaemoglobin–cyanide
Digoxin Magnesium sulphate i.v. 25–50 mg/kg (0.1–0.2 mmol/kg) Antagonises digoxin at sarcolemma
Digoxin Fab i.v: acute – 10 vials per 25 tablets (0.25 mg each), 10 vials per 5 mg elixir; steady state: vials, serum digoxin(ng/ml) × BW(kg)/100 Binds digoxin
Ergotamine Sodium nitroprusside infusion 0.5–5.0 μg/kg per min Treats vasoconstriction. Monitor BP continuously
Heparin i.v. 100 units/kg then 10–30 units/kg per hour Monitor partial thromboplastin time
Lead Dimercaprol (BAL) i.m. 75 mg/m2 4-hourly, six doses, then i.v. CaNa2 edetate (EDTA) 1500 mg/m2 over 5 days if blood level >3.38 μmol/l If asymptomatic and blood level 2.65–3.3 μmol/l, infuse CaNa2EDTA 1000 mg/m2 per day 5 days or oral succimer 350 mg/m2 8-hourly 5 days, then 12-hourly 14 days Chelating agents
Heparin Protamine 1 mg/100 units heparin Direct neutralisation
Iron Desferrioxamine 15 mg/kg per hour 12–24 hours if serum iron >90 μmol/l (500 μg/dl) or >63 μmol/l (350 μg/dl) and symptomatic Give slowly, beware anaphylaxis
Methanol, ethylene glycol, glycol ethers Ethanol i.v. loading dose 10 ml/kg 10% diluted in glucose 5%, then 0.15 ml/kg per hour to maintain blood level 0.1% (100 mg/dl) Competes with poison for alcohol dehydrogenase
Fomepizole (4-methylpyrazole) 15 mg/kg over 30 minutes, then 10 mg/kg 12-hourly, four doses. (Not available in Australia) Inhibits alcohol dehydrogenase
Methaemoglobinaemia Methylene blue i.v. 1–2 mg/kg over several minutes Reduces methaemoglobin to haemoglobin
Opiates Naloxone i.v. 0.01–0.1 mg/kg, then 0.01 mg/kg per hour as needed Direct receptor antagonist
Organophosphates and carbamates Atropine i.v. 20–50 μg/kg every 15 minutes until secretions dry Blocks muscarinic effects
Pralidoxime i.v. 25 mg/kg over 15–30 minutes then 10–20 mg/kg per hour for 18 hours or more. Not for carbamates Reactivates cholinesterase
Paracetamol N-acetylcysteine i.v. 150 mg/kg in dextrose 5% over 60 minutes then 10 mg/kg per hour for 20–72 hours OR oral 140 mg/kg then 17 doses of 70 mg/kg 4-hourly (total 1330 mg/kg over 68 hours) Restores glutathione inhibiting metabolites. Give if serum paracetamol exceeds 1500 μmol/l at 2 hours, 1000 at 4 hours, 500 at 8 hours, 200 at 12 hours, 80 at 16 hours, 40 at 20 hours. Beware anaphylaxis
Phenothiazine dystonia Benzatropine i.v or i.m. 0.01–0.03 mg/kg Blocks dopamine reuptake
Potassium Calcium chloride 10% i.v. 0.2 ml/kg Antagonises cardiac effects
Sodium bicarbonate i.v. 1 mmol/kg Decreases serum potassium (slight effect). Beware hypocalcaemia
Glucose i.v. 0.5 g/kg plus insulin i.v. 0.05 units/kg Decreases serum potassium (rapid marked effect). Monitor serum glucose
Salbutamol aerosol 0.25 mg/kg Decreases serum potassium (rapid marked effect)
Resonium oral or rectal 0.5–1 g/kg Absorbs potassium (slow effect)
Sulphonyl ureas Glucose Octreotide 1–2 μg/kg 8-hourly Inhibits insulin release
Tricyclic antidepressants Sodium bicarbonate i.v. 1 mmol/kg to maintain blood pH >7.45 Reduces cardiotoxicity

Individual poisons may require specific measures. Consult toxicology texts46 for details.

The vast majority of poisoning in childhood is by ingestion. The correct choice of a gastrointestinal decontamination technique is crucial to uncomplicated recovery. The choices are induced emesis, gastric lavage, activated charcoal, whole-bowel irrigation or a combination of these techniques. The efficacy, indications, contraindications and disadvantages and complications of these techniques are discussed below. A general plan of management is presented in Figure 105.1.

A crucial point in management is initial recognition that the patient is in a state of either ‘full-consciousness’ or ‘less-than-full consciousness’. Traditionally, management has been dependent on a judgement of whether the gag reflex is present or absent, but in practice this is rarely tested. Since aspiration pneumonitis is a common feature of poisoning management, particularly among (but not confined to) CNS obtunded patients, it is prudent to regard all obtunded patients as having incompetent pharyngeal reflexes.

The decision to attempt removal of a poison should always be made with due reference to two facts

Occasionally, removal from the circulation by charcoal haemoperfusion, plasmafiltration or haemofiltration is indicated.

INDUCED EMESIS

Induced emesis is quickly disappearing from hospital practice and should not be performed routinely in this setting.7 It does not improve outcome and may reduce effectiveness of the alternative treatments of activated charcoal, oral antidotes and whole-bowel irrigation.

Specific contraindications include actual or impending loss of full consciousness or ingestion of corrosives or hydrocarbons.7

Syrup of Ipecacuanha has superseded other more injurious substances as emetic agents. It contains alkaloids, mainly emetine and cephaeline, which induce emesis by stimulation of the chemoreceptor trigger zone of the medulla and by irritation of the gastric mucosa.

The efficacy of ipecacuanha (ipecac) is limited and decreases with time from ingestion. Although it causes vomiting in a high percentage (93–100%) of children within 25 minutes, the percentage of stomach contents ejected is small (28%) even when administered immediately after ingestion.8 Moreover, solids are retained in the stomach or may even be propelled into the duodenum.9

In experimental drug ingestions, approximately 50–83% of ingested experimental drug is removed if ipecac is given after 5 minutes,10 but falling to 2–44% if given at 30 or 60 minutes.1115 In paediatric paracetamol poisoning, the 4-hour postingestion serum level was approximately 50% of controls if ipecac-induced vomiting occurred within 60 minutes of ingestion, but no benefit was derived if emesis occurred beyond 90 minutes after ingestion.16 Similarly, serum levels of paracetamol were reduced approximately 50% if ipecac was administered at home, inducing emesis at a mean of 26 minutes after ingestion, compared with ipecac administered at a medical facility at a mean of 83 minutes.17

In adults, ipecac is even less useful and has to be given immediately to have quantifiable effects.18

Induced emesis appears superior to gastric lavage but inferior to activated charcoal. In children poisoned with salicylate, emesis retrieved twice as much compared with gastric lavage.19 In adult volunteers ipecac-induced vomiting, occurring at an average of 19 minutes after ingestion, removed 54% of a tracer compared with 30% with gastric lavage performed at the equivalent times after ingestion.2022

The use of ipecac has potential complications:

More serious, but rare complications include:

Critics claim that induced emesis merely creates work, delays discharge from the emergency department,24 increases complications24 and does not benefit the patient who presents more than 1 hour after ingestion.25 Importantly, ipecac did not alter the clinical outcome of patients who presented awake and alert to the emergency department.26

Induced emesis has been largely abandoned by emergency departments but its use in the home is safe and is associated with fewer paediatric emergency department attendances.27 Its use at home is still recommended by authoritative paediatric health organisations in the USA28 and by approximately half of poison centre staff.29 Although ipecac was recommended inappropriately in 20% of cases to poisons information centres, it caused little morbidity.30